All Type of News
KFDA establish Evaluation Division of biological equivalence
KFDA plans to promote the establishment of biological equivalence evaluation division so as to devote all their energies in intensified post-management of medicine and go smoothly biological equivalence test.
Als...
Anti-Zuellig Committee put on action.
The Anti-Zuellig Committee, a private committee organized with representatives from ethical drug wholesale companies, decided not to recognize the entity of Zuellig and put their strengths all together for a substanti...
Exclusion of injectable drugs against basic principle of medical reform program.
The civic group strongly protested against the recent government's NHI financial stabilization measures announced on May 31 that encompassed the increase of patient's own deductable payment, the exclusion of injectabl...
KMA's 6·3 Assembly be held in an absolute frenzy
Dissention between medical circles went to extremes.
KMA held 'National Doctors Resolution Assembly' opposing to government's wrong medical program at the front of Gwachon Government Complex on June 3, however, wh...
Cheiljedang released breast cancer drug, Genexol to market.
Cheiljedang announced that Paclitaxel preparation, the first domestic anti-breast cancer drug, was ready to release its sales on the market, the main ingredient of which was originally developed by Samyang in a massiv...
Medicine Logistics Cooperative hold general meeting for establishment on June 19
Medicine logistics cooperative association come out the principle body in distribution innovation.
As holding standing committee recently and deciding to invest 3 billion won, its logistics cooperative ensured adm...
False·exaggerated Ad of Health supplementary food be on the decreasing trend
It appeared that the false·exaggerated advertisement of health supplementary food keeps decreasing.
Korea Health Food & Special Nutritive Food Association announced that only 56 cases, 10.6 percent, out of total 5...
"Insured Medicine Price should be calculated at '85%'"
Regarding the 'Comprehensive Measures to stabilize the finance of Medical Insurance and settle the system separating the roles of pharmacists and doctors' disclosed by the Government, the Korean Pharmaceutical Manufac...
Gleevec, a new medicine for leukemia, to be sold in June.
Designated as an orphan drug, Gleevec, the leukemia remedy of Novartis, is likely to be sold in June.
Having held a Central Medical Council on May 31, the Korea Food and Drug Administration (KFDA) formed a conclusi...
Biotech products development·efficacy equivalence test concentration
The Korea Food and Drug Administration (KFDA) plans to make a concentrated investment in development of biotechnology products and their safety management·efficacy equivalence test management next year.
KFDA settle...
